Scientific Sessions 2024  /  What’s the Latest in Interventional Cardiology? Clinical Trial and Science Update from TCT/ESC/AHA  /  EARLY-TAVR (primary results at TCT)
Logo

American Heart Association

  140
  0

Final ID:

EARLY-TAVR (primary results at TCT)

  • Genereux, Philippe  ( Atlantic Medical System , Morristown , New Jersey , United States )
  • Leon, Martin  ( COLUMBIA UNIVERSITY MEDICAL CTR , New York , New York , United States )
    • Author Disclosures:
    Philippe Genereux: DO have relevant financial relationships ; Consultant:edwards lifesciences:Active (exists now) ; Consultant:puzzle medical:Active (exists now) | Martin Leon: DO have relevant financial relationships ; Advisor:Medtronic:Active (exists now) ; Consultant:Anteris:Active (exists now) ; Individual Stocks/Stock Options:Picardia:Active (exists now) ; Ownership Interest:Concept Medical:Active (exists now) ; Individual Stocks/Stock Options:Cathworks:Active (exists now) ; Individual Stocks/Stock Options:Medinol:Active (exists now) ; Consultant:Bain Capital:Active (exists now) ; Advisor:Edwards Lifescience:Active (exists now) ; Advisor:Boston Scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

What’s the Latest in Interventional Cardiology? Clinical Trial and Science Update from TCT/ESC/AHA

Saturday, 11/16/2024 , 03:15PM - 04:30PM

Hall

More abstracts on this topic:
Panel Discussion

Moller Jacob

TRISCEND II 1-Year Outcomes (primary results at TCT)

Hahn Rebecca, Thourani Vinod, Kodali Susheel

More abstracts from these authors:
Beyond the Guidelines: Debate: Severe Asymptomatic Aortic Stenosis Patients Should Get TAVR

Pibarot Philippe, Genereux Philippe, Szerlip Molly, Hahn Rebecca, Boskovski Marko, Leon Martin, Hamilton Barbara

Early TAVR Trial: Latest Updates of Early TAVR in Severe Asymptomatic Aortic Stenosis Patients

Genereux Philippe, Leon Martin, Mack Michael, Hahn Rebecca

You have to be authorized to contact abstract author. Please, Login
Not Available